Date Filed | Type | Description |
02/02/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
03/13/2017 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
03/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
03/07/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
03/06/2017 |
8-K/A
| Quarterly results |
02/28/2017 |
SC 13D/A
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 0% stake in Derma Sciences, Inc. |
02/24/2017 |
4
| NAVARRO SAMUEL E (Director) has filed a Form 4 on DERMA SCIENCES, INC. |
02/24/2017 |
4
| WILLS STEPHEN T (Director) has filed a Form 4 on DERMA SCIENCES, INC. |
02/24/2017 |
4
| COLE ROBERT C (See Remarks) has filed a Form 4 on DERMA SCIENCES, INC.
Txns:
| Disposed/sold 69,518 shares
@ $0 Disposed/sold 83,482 options to buy
@ $0 |
|
02/24/2017 |
4
| Eigner Frederic (Executive VP - Operations) has filed a Form 4 on DERMA SCIENCES, INC. |
02/24/2017 |
4
| Hewlett Brett (Director) has filed a Form 4 on DERMA SCIENCES, INC.
Txns:
| Disposed/sold 51,250 shares
@ $0 Disposed/sold 17,500 shares
@ $0 Disposed/sold 20,000 options to buy
@ $0 Disposed/sold 17,500 restricted stock units
@ $0 |
|
02/24/2017 |
4
| CONJEEVARAM SRINI (Director) has filed a Form 4 on DERMA SCIENCES, INC. |
02/24/2017 |
4
| YETTER JOHN E (EVP, Finance & CFO) has filed a Form 4 on DERMA SCIENCES, INC. |
02/24/2017 |
4
| MOUSSA ROBERT G (Director) has filed a Form 4 on DERMA SCIENCES, INC. |
02/24/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
02/24/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
02/24/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
02/24/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
02/24/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
02/24/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
02/24/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
02/24/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
02/24/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
02/24/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
02/24/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
02/24/2017 |
8-K
| Form 8-K - Current report |
02/23/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
02/16/2017 |
4
| Eigner Frederic (Executive VP - Operations) has filed a Form 4 on DERMA SCIENCES, INC. |
02/16/2017 |
4
| YETTER JOHN E (EVP, Finance & CFO) has filed a Form 4 on DERMA SCIENCES, INC. |
02/16/2017 |
4
| COLE ROBERT C (See Remarks) has filed a Form 4 on DERMA SCIENCES, INC. |
02/16/2017 |
4
| CONJEEVARAM SRINI (Director) has filed a Form 4 on DERMA SCIENCES, INC. |
02/16/2017 |
4
| WILLS STEPHEN T (Director) has filed a Form 4 on DERMA SCIENCES, INC. |
02/16/2017 |
4
| MOUSSA ROBERT G (Director) has filed a Form 4 on DERMA SCIENCES, INC. |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|